Literature DB >> 16568375

Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis.

Takashi Ueda1, Yoshifumi Takeyama, Takeo Yasuda, Naoki Matsumura, Hidehiro Sawa, Takahiro Nakajima, Tetsuo Ajiki, Yasuhiro Fujino, Yasuyuki Suzuki, Yoshikazu Kuroda.   

Abstract

BACKGROUND: We have reported that peripheral lymphocyte reduction due to apoptosis is linked to the development of subsequent infectious complications in patients with severe acute pancreatitis and that Th1 (helper T cell type 1)/Th2 (helper T cell type 2) balance tends to cause Th1 suppression in experimental severe acute pancreatitis. It has been reported that interleukin (IL)-18 is a cytokine produced from Kupffer cells and activated macrophages, and that IL-18 acts on Th1 cells and in combination with IL-12 strongly induces production of interferon-gamma. However, the role of IL-18 in acute pancreatitis has not yet been fully understood.
METHODS: Serum IL-18 concentrations were determined by an enzyme-linked immunosorbent assay in 43 patients with acute pancreatitis at the time of admission. The relationships with etiology, pancreatic necrosis, severity, blood biochemical parameters on admission, infection, and organ dysfunction during the clinical course and prognosis were analyzed.
RESULTS: Serum IL-18 levels in patients with acute pancreatitis (656+/- 11pg/ml) were significantly higher than those in healthy volunteers (126+/- pg/ml). Serum IL-18 levels were significantly positively correlated with the Ranson score and Japanese severity score. Among the blood biochemical parameters on admission, base excess and total protein were significantly negatively correlated with serum IL-18 levels. Moreover, the CD4/CD8 rate of lymphocytes, serum IL-6 levels, and serum IL-8 levels were significantly positively correlated with serum IL-18 levels. On day 7 after admission, the CD4/CD8 rate of lymphocytes and the rate of CD4-positive lymphocytes were significantly positively correlated with serum IL-18 levels. Furthermore, serum IL-18 levels in patients with hepatic dysfunction (980+/- 25pg/ml) were significantly higher than those without hepatic dysfunction (464+/- 8pg/ml). Serum IL-18 levels were not related to infection or prognosis. Elevation of serum IL-18 levels continued during 4 weeks after admission.
CONCLUSIONS: These results suggest that serum IL-18 levels are significantly elevated and are correlated with severity in patients with acute pancreatitis and that IL-18 may be closely related to helper T cell response and hepatic dysfunction in this disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568375     DOI: 10.1007/s00535-005-1735-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  39 in total

1.  Development and use of a new staging system for severe acute pancreatitis based on a nationwide survey in Japan.

Authors:  Michio Ogawa; Masahiko Hirota; Tetsuo Hayakawa; Seiki Matsuno; Shinichiro Watanabe; Yutaka Atomi; Makoto Otsuki; Kei Kashima; Masaru Koizumi; Hideo Harada; Masahiro Yamamoto; Isao Nishimori
Journal:  Pancreas       Date:  2002-11       Impact factor: 3.327

2.  Evaluation of severity of acute pancreatitis. According to a report of the cooperative national survey in Japan.

Authors:  Y Saitoh; M Yamamoto
Journal:  Int J Pancreatol       Date:  1991

Review 3.  Pathophysiological roles of interleukin-18 in inflammatory liver diseases.

Authors:  H Tsutsui; K Matsui; H Okamura; K Nakanishi
Journal:  Immunol Rev       Date:  2000-04       Impact factor: 12.988

Review 4.  Interleukin-18, a proinflammatory cytokine.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  2000-09       Impact factor: 2.737

Review 5.  Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity.

Authors:  G Trinchieri
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

Review 6.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death.

Authors:  Y Takeyama; K Takas; T Ueda; Y Hori; M Goshima; Y Kuroda
Journal:  J Gastrointest Surg       Date:  2000 Jul-Aug       Impact factor: 3.452

8.  Thymic atrophy caused by thymocyte apoptosis in experimental severe acute pancreatitis.

Authors:  Y Takeyama; J Nishikawa; T Ueda; Y Hori
Journal:  J Surg Res       Date:  1998-08       Impact factor: 2.192

9.  Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis.

Authors:  R Isenmann; B Rau; H G Beger
Journal:  Br J Surg       Date:  1999-08       Impact factor: 6.939

10.  Splenic atrophy in experimental severe acute pancreatitis.

Authors:  Takeo Yasuda; Yoshifumi Takeyama; Takashi Ueda; Kozo Takase; Junsuke Nishikawa; Yoshikazu Kuroda
Journal:  Pancreas       Date:  2002-05       Impact factor: 3.327

View more
  30 in total

1.  Lipotoxicity causes multisystem organ failure and exacerbates acute pancreatitis in obesity.

Authors:  Sarah Navina; Chathur Acharya; James P DeLany; Lidiya S Orlichenko; Catherine J Baty; Sruti S Shiva; Chandra Durgampudi; Jenny M Karlsson; Kenneth Lee; Kyongtae T Bae; Alessandro Furlan; Jaideep Behari; Shiguang Liu; Teresa McHale; Larry Nichols; Georgios Ioannis Papachristou; Dhiraj Yadav; Vijay P Singh
Journal:  Sci Transl Med       Date:  2011-11-02       Impact factor: 17.956

2.  Significance of elevated serum IL-18 levels in patients with acute pancreatitis.

Authors:  Masahiko Hirota; Muneyuki Shibata; Hideo Baba
Journal:  J Gastroenterol       Date:  2006-02       Impact factor: 7.527

3.  Immunosuppression in patients with severe acute pancreatitis.

Authors:  Takashi Ueda; Yoshifumi Takeyama; Takeo Yasuda; Makoto Shinzeki; Hidehiro Sawa; Takahiro Nakajima; Tetsuo Ajiki; Yasuhiro Fujino; Yasuyuki Suzuki; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

4.  Acute lipotoxicity regulates severity of biliary acute pancreatitis without affecting its initiation.

Authors:  Chandra Durgampudi; Pawan Noel; Krutika Patel; Rachel Cline; Ram N Trivedi; James P DeLany; Dhiraj Yadav; Georgios I Papachristou; Kenneth Lee; Chathur Acharya; Deepthi Jaligama; Sarah Navina; Faris Murad; Vijay P Singh
Journal:  Am J Pathol       Date:  2014-06       Impact factor: 4.307

5.  Acute pancreatitis successfully diagnosed by diffusion-weighted imaging: a case report.

Authors:  Satoshi Shinya; Takamitsu Sasaki; Yoshifumi Nakagawa; Zhang Guiquing; Fumio Yamamoto; Yuichi Yamashita
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 6.  Organ Failure Due to Systemic Injury in Acute Pancreatitis.

Authors:  Pramod K Garg; Vijay P Singh
Journal:  Gastroenterology       Date:  2019-02-12       Impact factor: 22.682

7.  Role of eosinophils in the initiation and progression of pancreatitis pathogenesis.

Authors:  Murli Manohar; Alok K Verma; Sathisha Upparahalli Venkateshaiah; Anil Mishra
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-21       Impact factor: 4.052

8.  Efficacy and mechanism of Salvia miltiorrhizae injection in the treatment of rats with severe acute pancreatitis.

Authors:  Ruiping Zhang; Xiping Zhang; Jie Zhang; Junsheng Wu; Qian Ye; Rujun Xu; Jing Ye; Xin Fang; Lu Jin; Jiao He; Wenqin Yuan
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

9.  Serum profiles of C-reactive protein, interleukin-8, and tumor necrosis factor-alpha in patients with acute pancreatitis.

Authors:  Michael K Digalakis; Iraklis E Katsoulis; Kalliopi Biliri; Katina Themeli-Digalaki
Journal:  HPB Surg       Date:  2010-01-14

10.  Effect of diet-induced obesity on acute pancreatitis induced by administration of interleukin-12 plus interleukin-18 in mice.

Authors:  Maria Pini; Joseph A Sennello; Robert J Cabay; Giamila Fantuzzi
Journal:  Obesity (Silver Spring)       Date:  2009-08-20       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.